Molecular and Cellular Biology · 2000 · 195 citations · 86 references
Life SciencesCell BiologyMolecular BiologyCell SignalingGene ExpressionTranscriptional RegulationChromatinEnhancer FunctionGene Expression RegulationGene Regulatory ElementsPromoter RegulationTranscriptional Regulation In EukaryotesCell AggregationCorepressor RecruitmentCorepressor RegulationEnhancer-driven Transcriptional RegulationEnhancer-mediated Transcription ControlHistone DeacetylasesSignalingTranscriptional Repressors
The Hoxb1 autoregulatory element comprises three HOX-PBX binding sites. Despite the presence of HOXB1 and PBX1, this enhancer fails to activate reporter gene expression in retinoic acid-treated P19 cell monolayers. Activation requires cell aggregation in addition to RA. This suggests that HOX-PBX complexes may repress transcription under some conditions. Consistent with this, multimerized HOX-PBX binding sites repress reporter gene expression in HEK293 cells. We provide a mechanistic basis for repressor function by demonstrating that a corepressor complex, including histone deacetylases (HDACs) 1 and 3, mSIN3B, and N-CoR/SMRT, interacts with PBX1A. We map a site of interaction with HDAC1 to the PBX1 N terminus and show that the PBX partner is required for repression by the HOX-PBX complex. Treatment with the deacetylase inhibitor trichostatin A not only relieves repression but also converts the HOX-PBX complex to a net activator of transcription. We show that this activation function is mediated by the recruitment of the coactivator CREB-binding protein by the HOX partner. Interestingly, HOX-PBX complexes are switched from transcriptional repressors to activators in response to protein kinase A signaling or cell aggregation. Together, our results suggest a model whereby the HOX-PBX complex can act as a repressor or activator of transcription via association with corepressors and coactivators. The model implies that cell signaling is a direct determinant of HOX-PBX function in the patterning of the animal embryo.
86
Yasutomi Kamei, Lan Xu, Thorsten Heinzel et al. · Cell · 1996 · 2.2K citations · Full text
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Xiang‐Jiao Yang, Vasily Ogryzko, Jun‐ichi Nishikawa et al. · Nature · 1996 · 1.5K citations
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Fred Petrif, Rachel H. Giles, Hans G. Dauwerse et al. · Nature · 1995 · 1.2K citations